In addition, a peptide mimicking the function of VGLL4 acts as a YAP antagonist and potently suppresses tumor growth 128, suggesting that the VGLL4-mimicking peptide may be a promising therapeutic strategy against YAP-driven human cancers, however, its effect in pancreatic cancer has not been revealed. This evidence concerns the gene VGLL4 and pancreatic neoplasm.